Björk-Eriksson T - Search Results

1

Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up.

Nyqvist J, Fransson P, Laurell G, Hammerlid E, Kjellén E, Franzén L, Söderström K, Wickart-Johansson G, Friesland S, Sjödin H, Brun E, Ask A, Nilsson P, Ekberg L, Björk-Eriksson T, Nyman J, Lödén B, Lewin F, Reizenstein J, Lundin E, Zackrisson B. Nyqvist J, et al. Radiother Oncol. 2016 Feb;118(2):335-41. doi: 10.1016/j.radonc.2015.12.024. Epub 2016 Jan 6. Radiother Oncol. 2016. PMID: 26777124 Clinical Trial.

2

The in vitro radiosensitivity of human head and neck cancers.

Björk-Eriksson T, West CM, Karlsson E, Slevin NJ, Davidson SE, James RD, Mercke C. Björk-Eriksson T, et al. Br J Cancer. 1998 Jun;77(12):2371-5. doi: 10.1038/bjc.1998.394. Br J Cancer. 1998. PMID: 9649161 Free PMC article.

3

The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.

Björk-Eriksson T, West CM, Cvetskovska E, Svensson M, Karlsson E, Magnusson B, Slevin NJ, Edström S, Mercke C. Björk-Eriksson T, et al. Br J Cancer. 1999 Jul;80(9):1400-4. doi: 10.1038/sj.bjc.6690535. Br J Cancer. 1999. PMID: 10424742 Free PMC article.

4

MRI staging using gadodiamide for soft-tissue tumors of the head and neck region. Results from a phase II trial and a 5-year clinical follow-up.

Ekholm SE, Björk-Eriksson T, Western A, Nellström H, Jonsson E, Johansson A, Lönn L, Mercke C, Tollesson PO. Ekholm SE, et al. Eur J Radiol. 2001 Sep;39(3):168-75. doi: 10.1016/s0720-048x(01)00371-0. Eur J Radiol. 2001. PMID: 11566244 Clinical Trial.

5

Accuracy of tele-oncology compared with face-to-face consultation in head and neck cancer case conferences.

Stalfors J, Edström S, Björk-Eriksson T, Mercke C, Nyman J, Westin T. Stalfors J, et al. J Telemed Telecare. 2001;7(6):338-43. doi: 10.1258/1357633011936976. J Telemed Telecare. 2001. PMID: 11747635

6

Number of patients potentially eligible for proton therapy.

Glimelius B, Ask A, Bjelkengren G, Björk-Eriksson T, Blomquist E, Johansson B, Karlsson M, Zackrisson B. Glimelius B, et al. Acta Oncol. 2005;44(8):836-49. doi: 10.1080/02841860500361049. Acta Oncol. 2005. PMID: 16332591

7

The potential of proton beam radiation therapy in head and neck cancer.

Ask A, Björk-Eriksson T, Zackrisson B, Blomquist E, Glimelius B. Ask A, et al. Acta Oncol. 2005;44(8):876-80. doi: 10.1080/02841860500355991. Acta Oncol. 2005. PMID: 16332595 Review.

8

The potential of proton beam radiation for palliation and reirradiation.

Björk-Eriksson T, Ask A, Glimelius B. Björk-Eriksson T, et al. Acta Oncol. 2005;44(8):918-20. doi: 10.1080/02841860500355967. Acta Oncol. 2005. PMID: 16332602 Review.

9

"Distributed proton radiation therapy"--a new concept for advanced competence support.

Karlsson M, Björk-Eriksson T, Mattsson O, Mattsson S, Montelius A, Nilsson P, Zackrisson B. Karlsson M, et al. Acta Oncol. 2006;45(8):1094-101. doi: 10.1080/02841860600897876. Acta Oncol. 2006. PMID: 17118845

10

Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.

Hallqvist A, Rylander H, Björk-Eriksson T, Nyman J. Hallqvist A, et al. Acta Oncol. 2007;46(7):969-74. doi: 10.1080/02841860701316065. Acta Oncol. 2007. PMID: 17851846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters